<DOC>
	<DOCNO>NCT00356278</DOCNO>
	<brief_summary>This study determine whether combination virtual reality exposure therapy D-cycloserine reduce post-traumatic stress disorder symptom Iraq war veteran .</brief_summary>
	<brief_title>D-cycloserine Virtual Reality Exposure Treat Iraq War Veterans With PTSD</brief_title>
	<detailed_description>Post-traumatic stress disorder ( PTSD ) type anxiety disorder affect people witness experienced traumatic event . Veterans war increase risk develop PTSD experience war combat . Symptoms PTSD often include flashback nightmare , depression , anxiety uneasiness , feel emotionally numb distant toward others . Fortunately , PTSD treat , usually combination anti-depressants , anti-anxiety medication , therapy . Virtual reality exposure ( VRE ) therapy new type treatment help people overcome anxiety trauma face situation use virtual reality . D-cycloserine medication find enhance effect psychotherapy recent study . This study determine effectiveness VRE therapy plus D-cycloserine reducing PTSD symptom Iraq war veteran . During study , participant undergo one educational session five VRE session . The first session involve gather information , learn common reaction trauma , participate breathe relaxation approach . The following five session involve review memory Iraq watch virtual Iraq sequence . Each participant wear head-mounted display view scenario setting city , humvee convoy , scene relate combat . Participants randomly assign receive D-cycloserine , alprazolam ( anti-anxiety drug ) , placebo one half-hour VRE session . Prior first treatment session , participant undergo startle reaction procedure . This entail hear sudden tone last fraction second , view virtual reality scene . Three small electrode , attach participant 's face , measure number eye blink procedure . At several time throughout study , heart rate skin conductance also measure electrode . Collection saliva sample measurement blood pressure also occur several time study . Before , , immediately treatment , participant complete questionnaire . Participants contact 3 , 6 , 12 month treatment ass symptom schedule time interview , additional questionnaire , virtual reality-based assessment .</detailed_description>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Meets DSMIV criterion PTSD due Iraq military trauma Speaks English Healthy overall History mania , schizophrenia , psychoses Suicidal Current alcohol drug dependence Medication free within 2 week study entry medication take less daily past month medicine free within 4 week study entry anxiolytic medication take daily last month Pregnant Special medical condition , kidney insufficiency , chronic disease , history significant head injury Stabilized potentially data obscure medication glucocorticoid</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>D-Cycloserine</keyword>
	<keyword>Virtual Reality</keyword>
	<keyword>Exposure Therapy</keyword>
	<keyword>Veterans</keyword>
	<keyword>Cognitive Behavior Therapy</keyword>
	<keyword>Translational Research</keyword>
</DOC>